Study: Multidisciplinary transplantation evaluation shows promise for older adults

November 14, 2019

Older adults with blood cancers can benefit from a team-based, holistic evaluation before undergoing transplantation, according to a new study published today in Blood Advances. The study, which reported on a multidisciplinary clinic (MDC) at the University of Chicago Medical Center, found that patients treated with this approach experienced better transplantation outcomes and survival rates.

Most blood cancers that can be treated with hematopoietic cell transplantation (HCT) more frequently occur in patients 60 years of age and older, and HCT has been shown to be relatively effective for medically cleared older patients. Yet many physicians are hesitant to refer older patients for transplant due to concerns about potential complications. The MDC aimed to improve patient resiliency prior to transplant so that older patients are not excluded from the treatment based on age alone.

A team of care providers--including transplant physicians, transplant nurse practitioners, geriatricians or geriatric oncologists, infectious disease physicians, dieticians, and social workers--was assembled for patients being evaluated for transplant. Patients took self-assessment surveys on their physical, social, and emotional health, as well as clinic tests on mobility and cognition. The multidisciplinary team used the results to coordinate their recommendations and create integrative, individualized treatment plans.

Initially, the team at the clinic assessed patients 60 years of age and older being evaluated for allogeneic HCT. Based on the results, the approach was later expanded to include patients 70 years of age and older being evaluated for autologous HCT as well as CAR-T therapy. Some younger HCT patients were also electively referred to the clinic by their physician. The median age of all 247 patients referred to the clinic was 67.9 years.

Researchers found that compared to patients who had undergone transplants at the center prior to the establishment of the MDC, patients in the multidisciplinary setting experienced fewer complications, fewer admissions to nursing facilities, shorter hospital stays, and better survival. Moreover, the improved outcomes occurred without a reduction in the transplant regimen strength: 90% of autologous transplant patients 70 years and older received full doses of the drugs administered as preparation for HCT.

"We can help the patient achieve better results without sacrificing the treatment," said Andrew S. Artz, MD, of City of Hope National Medical Center, formerly of University of Chicago Medical Center, and the study's senior author. "In the past, physicians might give a lower intensity regimen or not offer transplant as their main treatment option. Now, we can strengthen the patient so we can offer the treatments that best address not only the patient's disease but also their individual needs and goals."

Although the findings are promising, the study is not a randomized controlled trial, so its approach warrants future research. The researchers hope that if subsequent studies confirm the findings, there will be wider, safer use of transplantation among older adults. "Our main goal is to allow more older patients who could benefit from transplant to be able to consider it as a treatment option. Deploying staff in this type of coordinated pre-transplant approach requires organization and effort, but we hope the upfront investment of time and energy might prevent more expensive problems later," said Dr. Artz.
Blood Advances, is a peer-reviewed, online only, open access journal of the American Society of Hematology (ASH), the world's largest professional society concerned with the causes and treatment of blood disorders.

Blood Advances is a registered trademark of the American Society of Hematology.

American Society of Hematology

Related Transplantation Articles from Brightsurf:

A revolutionary new treatment alternative to corneal transplantation
A new approach in ophthalmology that offers a revolutionary alternative to corneal transplantation has just been developed by researchers and clinicians in North America, Europe, and Oceania.

Fewer complications after organ transplantation
A large international study coordinated by University Hospital Regensburg and Charité - Universitätsmedizin Berlin has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients.

Elderly patients also benefit from kidney transplantation
So far, kidney transplantation has generally not been offered to elderly patients (>75 years) because of the perioperative risks.

New material will allow abandoning bone marrow transplantation
Scientists from the National University of Science and Technology 'MISIS' developed nanomaterial, which will be able to restore the internal structure of bones damaged due to osteoporosis and osteomyelitis.

Fewer medical tests -- timely listing for transplantation
Younger patients would benefit greatly from kidney transplantation. Their expected remaining lifetime may even be doubled by having a transplant.

Uterus transplantation -- ethically just as problematic as altruistic surrogacy
In 2014, the first child to have been gestated in a donated uterus was born.

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

Transplantation followed by antiviral therapy cured hepatitis C
Twenty patients who received kidneys transplanted from hepatitis C virus (HCV)-infected donors experienced HCV cure, good quality of life, and excellent renal function at one year.

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Older donor lungs should be considered for transplantation
With a scarcity of lungs available for transplantation, the use of lungs from donors older than age 60 has been shown to achieve reasonable outcomes and should be considered as a viable option, according to research published online today in The Annals of Thoracic Surgery.

Read More: Transplantation News and Transplantation Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to